Clinical Trial Update: Megakaryocyte Heterogeneity in Sickle Cell Disease

View source ↗

Summary

This clinical trial update reports an ongoing study examining megakaryocyte heterogeneity in sickle cell disease, with recruitment not yet started at the Centre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Centre Hospitalier Universitaire de la Guadeloupe | Conditions: Sickle Cell Disease (SCD) | Status: NOT_YET_RECRUITING